SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models
Luisa Quinti(Harvard University), Aleksey Kazantsev(Harvard University)
Cited by 87
Related Papers
Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease
|Science|2007|1.1k
Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor
|Circulation|2007|265
Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases
|Proceedings of the National Academy of Sciences|2006|258
List of Contributors
|Elsevier eBooks|2018|0